🆕 WHO Results Report 2023 is out!

The report showcases achievement of key public health milestones, even amid greater global humanitarian health needs driven by conflict, climate change and disease outbreaks bit.ly/3UNM8vp

#HealthForAll #InvestinWHO

“The development of new #antibiotics has been a priority for support and public financing by administrations in the EU and US.”

We ⁦CARB-X⁩ are grateful for support from ⁦BARDA⁩ ⁦BMBF⁩ ⁦Global Health Security, DHSC UK⁩ ⁦Health Canada and PHAC⁩! english.elpais.com/health/2024-05…

💼 CARB-X is hiring a CFO!

We are looking for a strategic thinker and communicator with a strong background in financial modeling and analysis. The CFO will oversee operational finances and collaborate on strategy with our Executive Team.

➡️ Apply today! bit.ly/3UQCYOJ

Join CARB-X's Chief of External Affairs, Damiano de Felice, PhD, at Foreign Policy’s “From Resistance to Resilience” event on May 14 from 6-8pm ET to learn about innovative approaches the private sector is taking to rise to the challenge of AMR.

🔗Register: foreignpolicy.com/events/from-re…

The Belgian Presidency of the Council of the EU 2024 #ConfAMR24 has started. Thanks #BelgianPresidency FPS Health for your leadership to address #AMR !

CARB-X stands ready to continue replenishing the global clinical pipeline with promising antibiotics, vaccines & diagnostics.

The time to #StopSuperbugs is now.

Great work Vedanta Biosciences & CARB-X 👏👏👏 #AMR

“Higher temperatures, more flooding, rising pollution & growing population crowding … add urgency to international efforts to #StopSuperbugs by developing new medicines & by blocking the pathways through which pathogen immunity spreads.”

We CARB-X stand ready to play our part.

CARB-X is doing its part - together with many others - to respond to the pipeline and access crisis.

GLG-ESCMID panelist Dr Erin Duffy, Chief of R&D CARB-X raises awareness about the lack of researchers in #AMR impacting the development of new antibiotics. She also notes innovation must be accompanied by access and stewardship for a sustainable pipeline of #antibiotics .

At our #ESCMIDGLG event, panellist and Chief of CARB-X Dr Erin Duffy shone a light on the various crises slowing down #AMR R&D and the development of a sustainable antibiotic pipeline, including the crises of innovation, access, investment and people. #AMR #ESCMIDGlobal

'You can't have innovation if you don't have proper stewardship' responded CARB-X's Dr Erin Duffy during our #GLG event Q&A, highlighting that innovation must be accompanied by access and stewardship, if we are striving for sustainable pipeline of antibiotics. #ESCMIDGlobal #AMR

💼 CARB-X is #hiring !

We are looking for a SENIOR ALLIANCE MANAGER to help manage our portfolio that includes antibiotics, vaccines, live biotherapeutics, bacteriophage, non-traditionals & more.

➡️ Apply today: bit.ly/3JqgCNH

New funding opportunity!

FIND is seeking manufacturers of point-of-care molecular tests for gonorrhoeae & chlamydia to accelerate product development, evaluation & market entry in low- and middle-income countries.

Apply by May 6 at 23:59 CEST.

🔗bit.ly/3UoftMU

🗞️ New interview!

CARB-X Chief of R&D Erin Duffy, PhD, spoke with PharmaVoice about how CARB-X is stepping up to address the world’s greatest bacterial threats to humans.

🔗 Full article: bit.ly/3TSwxc8

#AMR #StopSuperBugs #AntibioticResistance #GlobalHealth